Ferozsons Laboratories Limited Stock price

Equities

FEROZ

PK0005201014

Pharmaceuticals

End-of-day quote Pakistan S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
223.5 PKR -0.03% Intraday chart for Ferozsons Laboratories Limited +1.04% +1.30%
Sales 2024 * 19.62B 70.54M Sales 2025 * 23B 82.71M Capitalization 9.72B 34.95M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 0.5 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.42 x
P/E ratio 2024 *
8.5 x
P/E ratio 2025 *
6.26 x
Employees 1,680
Yield 2024 *
1.74%
Yield 2025 *
2.37%
Free-Float 72.55%
More Fundamentals * Assessed data
Dynamic Chart
Ferozsons Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Ferozsons Laboratories Limited Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Ferozsons Laboratories Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Ferozsons Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Ferozsons Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Ferozsons Laboratories Limited Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Ferozsons Laboratories Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Ferozsons Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 CI
Ferozsons Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
Ferozsons Laboratories Limited Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
Ferozsons Laboratories Limited Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Ferozsons Laboratories Limited Reports Earnings Results for the Third Quarter Ended March 31, 2021 CI
Ferozsons Laboratories Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020 CI
Ferozsons Laboratories Limited Proposes the Final Cash Dividend for the Year Ended 30 June 2020 CI
Ferozsons Laboratories Limited Reports Earnings Results for the Full Year Ended June 30, 2020 CI
More news
1 day+0.19%
1 week+1.07%
Current month-2.18%
1 month-6.41%
3 months+11.96%
6 months+59.09%
Current year+1.32%
More quotes
1 week
219.00
Extreme 219
225.00
1 month
219.00
Extreme 219
242.00
Current year
197.00
Extreme 197
256.49
1 year
132.52
Extreme 132.52
256.49
3 years
118.00
Extreme 118
353.32
5 years
60.33
Extreme 60.3264
353.32
10 years
60.33
Extreme 60.3264
901.39
More quotes
Managers TitleAgeSince
Chief Executive Officer - 92-12-31
Director of Finance/CFO - -
Chairman - 91-12-31
Members of the board TitleAgeSince
Chairman - 91-12-31
Chief Executive Officer - 92-12-31
Director/Board Member - 83-12-31
More insiders
Date Price Change Volume
24-03-27 223.5 -0.03% 12 300
24-03-27 223.6 +0.19% 13,700
24-03-26 223.1 -0.27% 2,200
24-03-25 223.7 +1.63% 24,700
24-03-22 220.2 -0.76% 3,800

End-of-day quote Pakistan S.E., March 26, 2024

More quotes
Ferozsons Laboratories Limited is a Pakistan-based holding company. The Company is primarily engaged in the importing, manufacturing and sale of pharmaceutical products and medical devices. The Company possesses brands in the areas of gastroenterology, hepatology, cardiology, and oncology, with an emerging presence in endocrinology as well as mother and child health the diabetes space. The Company offers a range of medical devices in the areas of cardiology, electrophysiology, endoscopy, gastroenterology, pulmonology, urology, and peripheral interventions. Its product portfolio includes pharmaceuticals, medical technologies, and export. The Company’s export markets are spread across Asia, Africa, and the Central Asian region. The Company's subsidiaries include BF Biosciences Limited, which is engaged in the import, manufacturing, and sale of pharmaceutical products and Farmacia, which is engaged in the sale and distribution of medicines and other related products.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
223.6 PKR
Average target price
325 PKR
Spread / Average Target
+45.37%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Ferozsons Laboratories Limited - Pakistan S.E.